ASTELLAS PHARMA EUROPE LTD.

Company number 02486792

Date	Type	Description	View / Download
05 Jan 2017	AA	Full accounts made up to 31 March 2016	(43 pages)
03 Jun 2016	AP01	Appointment of Mr Naoki Okamura as a director on 1 April 2016	(2 pages)
26 Apr 2016	AP01	Appointment of Mr Yukio Matsui as a director on 1 April 2016	(2 pages)
25 Apr 2016	TM01	Termination of appointment of Yasuo Sakae as a director on 1 April 2016	(1 page)
07 Apr 2016	AP01	Appointment of Mr Daniel Benjamin Matthias Schulze as a director on 4 April 2016	(2 pages)
23 Mar 2016	AR01	Annual return made up to 23 February 2016 with full list of shareholders Statement of capital on 2016-03-23 USD 143,683,554	(16 pages)
08 Mar 2016	TM01	Termination of appointment of Kenneth Wade Jones as a director on 25 February 2016	(1 page)
07 Mar 2016	TM01	Termination of appointment of Jerrold Howard Temko as a director on 22 February 2016	(1 page)
25 Nov 2015	AP01	Appointment of Mr Eugene Theodurus Jansen Van Rensburg as a director on 20 July 2015	(2 pages)
05 Oct 2015	TM01	Termination of appointment of Nicolaas Jacobus Stander as a director on 20 July 2015	(1 page)
25 Sep 2015	SH01	Statement of capital following an allotment of shares on 3 September 2015 USD 143,683,540	(10 pages)
26 Aug 2015	AA	Full accounts made up to 31 March 2015	(25 pages)
06 Jul 2015	AP01	Appointment of Mr Nicolaas Jacobus Stander as a director on 10 March 2015	(2 pages)
01 Apr 2015	AP01	Appointment of Mr Jerrold Howard Temko as a director on 10 March 2015	(2 pages)
24 Mar 2015	AR01	Annual return made up to 23 February 2015 with full list of shareholders Statement of capital on 2015-03-24 USD 143,683,524	(10 pages)
17 Mar 2015	SH01	Statement of capital following an allotment of shares on 4 February 2015 USD 137,000,026.00	(4 pages)
12 Feb 2015	RP04	Second filing of AR01 previously delivered to Companies House made up to 23 February 2014	(17 pages)
29 Sep 2014	AA	Full accounts made up to 31 March 2014	(22 pages)
25 Apr 2014	AP03	Appointment of Ms Sally Anne Hinchliffe as a secretary	(2 pages)
25 Mar 2014	AR01	Annual return made up to 23 February 2014 with full list of shareholders Statement of capital on 2014-03-25 USD 137,000,000 Statement of capital on 2015-02-12 USD 143,683,500 ANNOTATION Clarification a second filed AR01 was registered on 12/02/2015	(5 pages)
13 Dec 2013	AA	Full accounts made up to 31 March 2013	(22 pages)
20 Nov 2013	AP01	Appointment of Mr Yasuo Sakae as a director	(2 pages)
07 Nov 2013	TM01	Termination of appointment of Hiroshi Nogawa as a director	(1 page)
18 Oct 2013	SH01	Statement of capital following an allotment of shares on 24 September 2013 USD 143,683,500	(4 pages)
18 Oct 2013	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities	(2 pages)